T cell activation profiles in different granulomatous interstitial lung diseases - A role for CD8+CD28null cells?

Clinical and Experimental Immunology

Volumn 160, Issue 2, 2010, Pages 256-265

  Heron, M ^a,b   Claessen, A M E ^b   Grutters, J C ^a,c   Van Den Bosch, J M M ^a,c  

^a Center for Interstitial Lung Diseases   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Activation; Expression; Hypersensitivity pneumonitis; Sarcoidosis; T lymphocytes

Indexed keywords

CARBON MONOXIDE; CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; CORTICOSTEROID; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; VERY LATE ACTIVATION ANTIGEN 1; VERY LATE ACTIVATION ANTIGEN 4;

ADULT; AGED; ALLERGIC PNEUMONITIS; ARTICLE; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COMPARTMENTALIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG DIFFUSION; LUNG LAVAGE; LUNG PARENCHYMA; LUNG SARCOIDOSIS; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; THORAX RADIOGRAPHY;

ADRENAL CORTEX HORMONES; ADULT; AGED; ALVEOLITIS, EXTRINSIC ALLERGIC; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD8; BRONCHOALVEOLAR LAVAGE FLUID; CARBON MONOXIDE; FEMALE; GRANULOMA; HLA-DR ANTIGENS; HUMANS; IMMUNOPHENOTYPING; LUNG DISEASES, INTERSTITIAL; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PULMONARY DIFFUSING CAPACITY; SARCOIDOSIS, PULMONARY; T-LYMPHOCYTE SUBSETS; YOUNG ADULT;

EID: 77950670526     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2009.04076.x     Document Type: Article

References (29)

1. Henke CE, Henke G, Elveback LR, Beard CM, Ballard DJ, Kurland LT. The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study of incidence and survival. Am J Epidemiol 1986 123 : 840 845.
2. Hillerdal G, Nou E, Osterman K, Schmekel B. Sarcoidosis: epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis 1984 130 : 29 32.
3. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997 336 : 1224 1234.
4. Crystal RG, Bitterman PB, Rennard SI, Hance AJ, Keogh BA. Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med 1984 310 : 235 244.
5. Bourke SJ, Dalphin JC, Boyd G, McSharry C, Baldwin CI, Calvert JE. Hypersensitivity pneumonitis: current concepts. Eur Respir J Suppl 2001 32 : 81s 92s.
6. Keogh BA, Crystal RG. Alveolitis: the key to the interstitial lung disorders. Thorax 1982 37 : 1 10.
7. Semenzato G, Adami F, Maschio N, Agostini C. Immune mechanisms in interstitial lung diseases. Allergy 2000 55 : 1103 1120.
8. Braun RK, Foerster M, Grahmann PR, Haefner D, Workalemahu G, Kroegel C. Phenotypic and molecular characterization of CD103+ CD4+ T cells in bronchoalveolar lavage from patients with interstitial lung diseases. Cytometry B Clin Cytom 2003 54 : 19 27.
9. Hemler ME, Jacobson JG, Brenner MB, Mann D, Strominger JL. VLA-1: a T cell surface antigen which defines a novel late stage of human T cell activation. Eur J Immunol 1985 15 : 502 508.
10. Testi R, Phillips JH, Lanier LL. T cell activation via Leu-23 (CD69). J Immunol 1989 143 : 1123 1128.
11. Sancho D, Gomez M, Sanchez-Madrid F. CD69 is an immunoregulatory molecule induced following activation. Trends Immunol 2005 26 : 136 140.
12. Wahlstrom J, Berlin M, Skold CM, Wigzell H, Eklund A, Grunewald J. Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis. Thorax 1999 54 : 339 346.
13. Grunewald J, Olerup O, Persson U, Ohrn MB, Wigzell H, Eklund A. T-cell receptor variable region gene usage by CD4+ and CD8+ T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients. Proc Natl Acad Sci USA 1994 91 : 4965 4969.
14. Katchar K, Wahlstrom J, Eklund A, Grunewald J. Highly activated T-cell receptor AV2S3(+) CD4(+) lung T-cell expansions in pulmonary sarcoidosis. Am J Respir Crit Care Med 2001 163 : 1540 1545.
15. Berlin M, Lundahl J, Skold CM, Grunewald J, Eklund A. The lymphocytic alveolitis in sarcoidosis is associated with increased amounts of soluble and cell-bound adhesion molecules in bronchoalveolar lavage fluid and serum. J Intern Med 1998 244 : 333 340.
16. Saltini C, Hemler ME, Crystal RG. T lymphocytes compartmentalized on the epithelial surface of the lower respiratory tract express the very late activation antigen complex VLA-1. Clin Immunol Immunopathol 1988 46 : 221 233.
17. Lohmeyer J, Friedrich J, Grimminger F et al. Expression of mucosa-related integrin alphaEbeta7 on alveolar T cells in interstitial lung diseases. Clin Exp Immunol 1999 116 : 340 346.
18. Heron M, Slieker WA, Zanen P et al. Evaluation of CD103 as a cellular marker for the diagnosis of pulmonary sarcoidosis. Clin Immunol 2008 126 : 338 344.
19. Hunninghake GW, Costabel U, Ando M et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999 16 : 149 173.
20. Grutters JC, van den Bosch JM. Corticosteroid treatment in sarcoidosis. Eur Respir J 2006 28 : 627 636.
21. Roberts SD, Kohli LL, Wood KL, Wilkes DS, Knox KS. CD4+CD28-T cells are expanded in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2005 22 : 13 9.
22. Bryl E, Vallejo AN, Weyand CM, Goronzy JJ. Down-regulation of CD28 expression by TNF-alpha. J Immunol 2001 167 : 3231 3238.
23. Vallejo AN, Weyand CM, Goronzy JJ. T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection. Trends Mol Med 2004 10 : 119 124.
24. Cortesini R, LeMaoult J, Ciubotariu R, Cortesini NS. CD8+. Immunol Rev 2001 182 : 201 206.
25. Baars PA, Ribeiro Do Couto LM, Leusen JH et al. Cytolytic mechanisms and expression of activation-regulating receptors on effector-type CD8+CD45RA+. J Immunol 2000 165 : 1910 1917.
26. Hamann D, Baars PA, Rep MH et al. Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med 1997 186 : 1407 1418.
27. Czesnikiewicz-Guzik M, Lee WW, Cui D et al. T cell subset-specific susceptibility to aging. Clin Immunol 2008 127 : 107 118.
28. Effros RB, Boucher N, Porter V et al. Decline in CD28+ T cells in centenarians and in long-term T cell cultures: a possible cause for both in vivo and in vitro immunosenescence. Exp Gerontol 1994 29 : 601 609.
29. Judson MA, Baughman RP, Teirstein AS, Terrin ML, Yeager H, Jr. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A case control etiologic study of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999 16 : 75 86.